SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001437749-23-024786
Filing Date
2023-08-29
Accepted
2023-08-28 17:40:16
Documents
7

Document Format Files

Seq Description Document Type Size
1 FORM S-3 navb20230828_s3.htm S-3 284287
2 EXHIBIT 4.10 ex_565188.htm EX-4.10 112216
3 EXHIBIT 5.1 ex_565299.htm EX-5.1 7570
4 EXHIBIT 23.1 ex_565158.htm EX-23.1 3202
5 EXHIBIT FILING FEES ex_565186.htm EX-FILING FEES 24099
6 logo03.jpg GRAPHIC 16880
7 logo04.jpg GRAPHIC 3228
  Complete submission text file 0001437749-23-024786.txt   460151
Mailing Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017
Business Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-274246 | Film No.: 231217384
SIC: 2835 In Vitro & In Vivo Diagnostic Substances